Cargando…

Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis

IgA vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, is the most common cause of systemic vasculitis in childhood. Given its potential life-threatening systemic complications, early and accurate diagnosis as well as management of IgAV represent a major challenge for health care profess...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Zaid, Mohammed Hassan, Salah, Samia, Lotfy, Hala M., El Gaafary, Maha, Abdulhady, Hala, Tabra, Samar abd Alhamed, Salah, Hala, Farag, Yomna, Eissa, Mervat, Maher, Sheren Esam, Radwan, Ahmed, El-Shanawany, Amira Tarek, Medhat, Basma M., El Mikkawy, Dalia, Mosad Mosa, Doaa, El Deriny, Ghada, Mortada, Mohamed, Osman, Naglaa S., Fouad, Nermeen Ahmed, Elkaraly, Nourhan Elameen, Mohamed, Sally S., Hassan, Waleed A., Amer, Youmna A., Nasef, Samah Ismail, El Miedany, Yasser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669874/
https://www.ncbi.nlm.nih.gov/pubmed/34917176
http://dx.doi.org/10.1177/1759720X211059610
_version_ 1784614867193298944
author Abu-Zaid, Mohammed Hassan
Salah, Samia
Lotfy, Hala M.
El Gaafary, Maha
Abdulhady, Hala
Tabra, Samar abd Alhamed
Salah, Hala
Farag, Yomna
Eissa, Mervat
Maher, Sheren Esam
Radwan, Ahmed
El-Shanawany, Amira Tarek
Medhat, Basma M.
El Mikkawy, Dalia
Mosad Mosa, Doaa
El Deriny, Ghada
Mortada, Mohamed
Osman, Naglaa S.
Fouad, Nermeen Ahmed
Elkaraly, Nourhan Elameen
Mohamed, Sally S.
Hassan, Waleed A.
Amer, Youmna A.
Nasef, Samah Ismail
El Miedany, Yasser
author_facet Abu-Zaid, Mohammed Hassan
Salah, Samia
Lotfy, Hala M.
El Gaafary, Maha
Abdulhady, Hala
Tabra, Samar abd Alhamed
Salah, Hala
Farag, Yomna
Eissa, Mervat
Maher, Sheren Esam
Radwan, Ahmed
El-Shanawany, Amira Tarek
Medhat, Basma M.
El Mikkawy, Dalia
Mosad Mosa, Doaa
El Deriny, Ghada
Mortada, Mohamed
Osman, Naglaa S.
Fouad, Nermeen Ahmed
Elkaraly, Nourhan Elameen
Mohamed, Sally S.
Hassan, Waleed A.
Amer, Youmna A.
Nasef, Samah Ismail
El Miedany, Yasser
author_sort Abu-Zaid, Mohammed Hassan
collection PubMed
description IgA vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, is the most common cause of systemic vasculitis in childhood. Given its potential life-threatening systemic complications, early and accurate diagnosis as well as management of IgAV represent a major challenge for health care professionals. This study was carried out to attain an evidence-based expert consensus on a treat-to-target management approach for IgAV using Delphi technique. The preliminary scientific committee identified a total of 16 key clinical questions according to the patient, intervention, comparison, and outcomes (PICO) approach. An evidence-based, systematic, literature review was conducted to compile evidence for the IgAV management. The core leadership team identified researchers and clinicians with expertise in IgAV management in Egypt upon which experts were gathered from different governorates and health centers across Egypt. Delphi process was implemented (two rounds) to reach a consensus. An online questionnaire was sent to expert panel (n = 26) who participated in the two rounds. After completing round 2, a total of 20 recommendation items, categorized into two sections were obtained. Agreement with the recommendations (rank 7–9) ranged from 91.7–100%. Consensus was reached (i.e. ⩾75% of respondents strongly agreed or agreed) on the wording of all the 20 clinical standards identified by the scientific committee. Algorithms for the diagnosis and management have been suggested. This was an expert, consensus recommendations for the diagnosis and treatment of IgAV and IgA vasculitic nephritis, based on best available evidence and expert opinion. The guideline presented a strategy of care with a pathway to achieve a state of remission as early as possible. PLAIN LANGUAGE SUMMARY: Given its potential life-threatening systemic complications, early and accurate diagnosis of immunoglobulin A vasculitis represents a major challenge for health care professionals. This work provided cornerstone principles for the management of the condition. Adopting PICO approach and implementing Delphi process a consensus was reached on evidence-based treat-to-target treatment recommendations. This will endorse enhancement and consistency of care of this cohort of patients in standard practice.
format Online
Article
Text
id pubmed-8669874
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-86698742021-12-15 Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis Abu-Zaid, Mohammed Hassan Salah, Samia Lotfy, Hala M. El Gaafary, Maha Abdulhady, Hala Tabra, Samar abd Alhamed Salah, Hala Farag, Yomna Eissa, Mervat Maher, Sheren Esam Radwan, Ahmed El-Shanawany, Amira Tarek Medhat, Basma M. El Mikkawy, Dalia Mosad Mosa, Doaa El Deriny, Ghada Mortada, Mohamed Osman, Naglaa S. Fouad, Nermeen Ahmed Elkaraly, Nourhan Elameen Mohamed, Sally S. Hassan, Waleed A. Amer, Youmna A. Nasef, Samah Ismail El Miedany, Yasser Ther Adv Musculoskelet Dis Review IgA vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, is the most common cause of systemic vasculitis in childhood. Given its potential life-threatening systemic complications, early and accurate diagnosis as well as management of IgAV represent a major challenge for health care professionals. This study was carried out to attain an evidence-based expert consensus on a treat-to-target management approach for IgAV using Delphi technique. The preliminary scientific committee identified a total of 16 key clinical questions according to the patient, intervention, comparison, and outcomes (PICO) approach. An evidence-based, systematic, literature review was conducted to compile evidence for the IgAV management. The core leadership team identified researchers and clinicians with expertise in IgAV management in Egypt upon which experts were gathered from different governorates and health centers across Egypt. Delphi process was implemented (two rounds) to reach a consensus. An online questionnaire was sent to expert panel (n = 26) who participated in the two rounds. After completing round 2, a total of 20 recommendation items, categorized into two sections were obtained. Agreement with the recommendations (rank 7–9) ranged from 91.7–100%. Consensus was reached (i.e. ⩾75% of respondents strongly agreed or agreed) on the wording of all the 20 clinical standards identified by the scientific committee. Algorithms for the diagnosis and management have been suggested. This was an expert, consensus recommendations for the diagnosis and treatment of IgAV and IgA vasculitic nephritis, based on best available evidence and expert opinion. The guideline presented a strategy of care with a pathway to achieve a state of remission as early as possible. PLAIN LANGUAGE SUMMARY: Given its potential life-threatening systemic complications, early and accurate diagnosis of immunoglobulin A vasculitis represents a major challenge for health care professionals. This work provided cornerstone principles for the management of the condition. Adopting PICO approach and implementing Delphi process a consensus was reached on evidence-based treat-to-target treatment recommendations. This will endorse enhancement and consistency of care of this cohort of patients in standard practice. SAGE Publications 2021-12-09 /pmc/articles/PMC8669874/ /pubmed/34917176 http://dx.doi.org/10.1177/1759720X211059610 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review
Abu-Zaid, Mohammed Hassan
Salah, Samia
Lotfy, Hala M.
El Gaafary, Maha
Abdulhady, Hala
Tabra, Samar abd Alhamed
Salah, Hala
Farag, Yomna
Eissa, Mervat
Maher, Sheren Esam
Radwan, Ahmed
El-Shanawany, Amira Tarek
Medhat, Basma M.
El Mikkawy, Dalia
Mosad Mosa, Doaa
El Deriny, Ghada
Mortada, Mohamed
Osman, Naglaa S.
Fouad, Nermeen Ahmed
Elkaraly, Nourhan Elameen
Mohamed, Sally S.
Hassan, Waleed A.
Amer, Youmna A.
Nasef, Samah Ismail
El Miedany, Yasser
Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis
title Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis
title_full Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis
title_fullStr Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis
title_full_unstemmed Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis
title_short Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis
title_sort consensus evidence-based recommendations for treat-to-target management of immunoglobulin a vasculitis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669874/
https://www.ncbi.nlm.nih.gov/pubmed/34917176
http://dx.doi.org/10.1177/1759720X211059610
work_keys_str_mv AT abuzaidmohammedhassan consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT salahsamia consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT lotfyhalam consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT elgaafarymaha consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT abdulhadyhala consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT tabrasamarabdalhamed consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT salahhala consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT faragyomna consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT eissamervat consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT mahersherenesam consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT radwanahmed consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT elshanawanyamiratarek consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT medhatbasmam consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT elmikkawydalia consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT mosadmosadoaa consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT elderinyghada consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT mortadamohamed consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT osmannaglaas consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT fouadnermeenahmed consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT elkaralynourhanelameen consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT mohamedsallys consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT hassanwaleeda consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT ameryoumnaa consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT nasefsamahismail consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis
AT elmiedanyyasser consensusevidencebasedrecommendationsfortreattotargetmanagementofimmunoglobulinavasculitis